Risk-Based Approach “Critical” To Securing Global Supply Chain – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA wants risk-based draft guidances it published this year to increase industry accountability and free resources for high-risk inspections as the number of foreign-sourced drugs entering the U.S. exceeds the agency's inspection capabilities
You may also be interested in...
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.